Literature DB >> 19214740

Mice with disrupted TGFbeta signaling have normal cerebella development, but exhibit facial dysmorphogenesis and strain-dependent deficits in their body wall.

Yoshiya Asano1, Kyoko Koishi, Tony Frugier, Ian S McLennan.   

Abstract

The transforming growth factor betas (TGFbetas) are context-dependent regulators of neurons in vitro, but their physiological functions in the brain are unclear. Haploinsufficiency of either Tgfbeta1 or Tgfbeta2 leads to age-related deterioration of neurons, but the development of the brain is normal in the full absence of either of these genes. However, some individuals with mis-sense mutations of TGFbeta receptors are mentally retarded, suggesting that the TGFbeta isoforms can compensate for each other during brain development. This possibility was tested by generating mice (NSE x PTR) with neuron-specific expression of a dominant-negative inhibitor of TGFbeta signaling. The NSE x PTR mice with a FVBxC57Bl/6 genetic background were viable and developed normally despite strong neuronal expression of the inhibitor of TGFbeta signaling. Their cerebella were of normal size and contained normal numbers of neurons. When the genetic background of the mice was changed to C57BL/6, the phenotype of the mice became neonatal lethal, with the neonates exhibiting various malformations. The malformations correlated with sites of non-neuronal expression of the transgenes and included facial dysmorphogenesis, incomplete closure of the ventral body wall and absence of intestinal motility. The C57BL/6 Tgfbm1-3 alleles, which modulate the phenotype of Tgfbeta1(-/-) mice, were not major determinants of the NSE x PTR phenotype. The data suggest that the development of the cerebellum is insensitive to the level of TGFbeta signaling, although this may be dependent on the genetic background.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19214740     DOI: 10.1007/s10571-009-9354-x

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  38 in total

Review 1.  Mechanisms of TGF-beta signaling from cell membrane to the nucleus.

Authors:  Yigong Shi; Joan Massagué
Journal:  Cell       Date:  2003-06-13       Impact factor: 41.582

Review 2.  Developmental disorders of the enteric nervous system: genetic and molecular bases.

Authors:  Cheryl E Gariepy
Journal:  J Pediatr Gastroenterol Nutr       Date:  2004-07       Impact factor: 2.839

3.  A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2.

Authors:  Bart L Loeys; Junji Chen; Enid R Neptune; Daniel P Judge; Megan Podowski; Tammy Holm; Jennifer Meyers; Carmen C Leitch; Nicholas Katsanis; Neda Sharifi; F Lauren Xu; Loretha A Myers; Philip J Spevak; Duke E Cameron; Julie De Backer; Jan Hellemans; Yan Chen; Elaine C Davis; Catherine L Webb; Wolfram Kress; Paul Coucke; Daniel B Rifkin; Anne M De Paepe; Harry C Dietz
Journal:  Nat Genet       Date:  2005-01-30       Impact factor: 38.330

Review 4.  Naturally occurring neuronal death during the postnatal development of Purkinje cells and their precerebellar afferent projections.

Authors:  Silvia H Madalosso; Eva M Pérez-Villegas; José A Armengol
Journal:  Brain Res Brain Res Rev       Date:  2004-11-05

5.  Epistatic interactions between modifier genes confer strain-specific redundancy for Tgfb1 in developmental angiogenesis.

Authors:  Yang Tang; Kyeong Sook Lee; HaiTao Yang; Darren W Logan; Susana Wang; Margaret L McKinnon; Liam J Holt; Alison Condie; Minh Thu Luu; Rosemary J Akhurst
Journal:  Genomics       Date:  2005-01       Impact factor: 5.736

6.  Mullerian inhibiting substance acts as a motor neuron survival factor in vitro.

Authors:  Pei-Yu Wang; Kyoko Koishi; Andrew B McGeachie; Michael Kimber; David T Maclaughlin; Patricia K Donahoe; Ian S McLennan
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-31       Impact factor: 11.205

7.  Decreased bone mass and bone elasticity in mice lacking the transforming growth factor-beta1 gene.

Authors:  A G Geiser; Q Q Zeng; M Sato; L M Helvering; T Hirano; C H Turner
Journal:  Bone       Date:  1998-08       Impact factor: 4.398

8.  Fetal and maternal transforming growth factor-beta 1 may combine to maintain pregnancy in mice.

Authors:  Ian S McLennan; Kyoko Koishi
Journal:  Biol Reprod       Date:  2004-02-06       Impact factor: 4.285

9.  Abnormal lung development and cleft palate in mice lacking TGF-beta 3 indicates defects of epithelial-mesenchymal interaction.

Authors:  V Kaartinen; J W Voncken; C Shuler; D Warburton; D Bu; N Heisterkamp; J Groffen
Journal:  Nat Genet       Date:  1995-12       Impact factor: 38.330

10.  TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes.

Authors:  L P Sanford; I Ormsby; A C Gittenberger-de Groot; H Sariola; R Friedman; G P Boivin; E L Cardell; T Doetschman
Journal:  Development       Date:  1997-07       Impact factor: 6.868

View more
  2 in total

1.  Myocardial deletion of Smad4 using a novel α skeletal muscle actin Cre recombinase transgenic mouse causes misalignment of the cardiac outflow tract.

Authors:  Mohamad Azhar; Pei-Yu Wang; Tony Frugier; Kyoko Koishi; Chuxia Deng; Peter G Noakes; Ian S McLennan
Journal:  Int J Biol Sci       Date:  2010-09-20       Impact factor: 6.580

2.  Mechanical stretch-induced endoplasmic reticulum stress, apoptosis and inflammation contribute to thoracic aortic aneurysm and dissection.

Authors:  Li-Xin Jia; Wen-Mei Zhang; Hong-Jia Zhang; Tao-Tao Li; Yue-Li Wang; Yan-Wen Qin; Hong Gu; Jie Du
Journal:  J Pathol       Date:  2015-04-27       Impact factor: 7.996

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.